The implementation of isoniazid preventive therapy in HIV clinics: The experience from the TB/HIV in Rio (THRio) Study

AIDS

Volumn 24, Issue SUPPL. 5, 2010, Pages

  Durovni, Betina ^a,b   Cavalcante, Solange C ^a,c   Saraceni, Valeria ^a   Vellozo, Vitoria ^a   Israel, Giselle ^a   King, Bonnie S ^d   Cohn, Silvia ^e   Efron, Anne ^d   Pacheco, Antonio G ^c   Moulton, Lawrence H ^d   Chaisson, Richard E ^d,e   Golub, Jonathan E ^d,e  

^a Municipal Health Secretariat   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adherence; HIV; implementation; isoniazid preventive therapy; tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRAZIL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG WITHDRAWAL; FEMALE; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

ANTITUBERCULAR AGENTS; BRAZIL; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; ISONIAZID; MALE; TUBERCULOSIS; VIRAL LOAD;

EID: 78649298939     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000391022.95412.a6     Document Type: Article

References (23)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-1021.
2. Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 2002; 34:543-546.
3. Jones JL, Hanson DL, Dworkin MS, DeCock KM, Adult/Adolescent Spectrum of HIV Disease Group. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 2000; 4:1026-1031.
4. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteeli A, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 2000; 14:1985-1991.
5. Badri M, Wilson D, Wood R. Effect of highly active antiretro-viral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359:2059-2064.
6. Whalen CC, Johnson JL, Okwera A, Horn DL, Huebner R, Mugyeni P, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337:801-808.
7. Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, et al. Randomised trial of isoniazid versus rifam-picin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 1998; 351:786-792.
8. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342:268-272.
9. Mwinga A, Hosp M, Godfrey-Fausset P, Quigley M, Mwaba P, Mugala BN, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12:2447-2457.
10. Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med 1997; 337:315-320.
11. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010:CD000171.
12. De Pinho AM, Santoro-Lopes G, Harrison LH, Schechter M. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. AIDS 2001; 15:2129-2135.
13. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva: WHO Press 2009. Report No. WHO/HTM/TB/2009.426.
14. Saraceni V, King BS, Cavalcante SC, Golub JE, Lauria LM, Moulton LH, et al. Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2008; 12:769-772.
15. Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, et al. AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS ONE 2008; 3:e3132.
16. Castelo Filho A, Kritski AL, Barreto AW, Lemos ACM, Netto AR, Gueimarares CA, et al. II Brazilian consensus on treatment of tuberculosis - Brazilian guidelines for tuberculosis 2004 [in Portuguese]. J Bras Pneumol 2004; 30 (Suppl 2):S62-S64.
17. Recommendations for antiretroviral therapy for adults infected with HIV: 2008/Ministry of Health, Secretary for Health Surveillance, National Program for DST and AIDS. 7th edition -Brasilia: Ministry of Health, 2008.
18. Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE). www.tbhiv-create.org. [accessed 17 June 2010]
19. Moulton L, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 2007; 4:190-199.
20. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, et al. The impact of antiretroviral therapy and iso-niazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21:1441-1448.
21. Saraceni V, Durovni B, King B, Eldred L, Chaisson RE. Physician adherence to HIV and TB guidelines in Rio de Janeiro, Brazil [abstract]. In: Programs and abstract of the 38th Union World Conference on Lung Health, International Union Against Tuberculosis and Lung Disease; 8-12 November 2007; Cape Town, South Africa.
22. Vellozo V, Israel G, Saraceni V, Ferreira R, Durovni B, DeLuca A. THRio qualitative study. In: Programs and abstract of the 39th Union World Conference on Lung Health, International Union Against Tuberculosis and Lung Disease; 16-20 October 2008; Paris, France.
23. World Health Orgainzation. Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva, Switzerland: WHO Press; 2010.